HK in the News
Hissey Kientz Announced Launch Of Online Legal Documents Database
The law firm of Hissey Kientz, LLP is pleased to announce the addition to its website of a new legal documents database containing medical studies, case law and other legal documents about many of the firm’s practice areas, including mesothelioma and asbestos cases, the Duragesic or fentanyl pain patch and Fleet Phospho-soda. More »
Yaz and Yasmin side effects website offers information to birth control users
The law firm of Hissey Kientz, LLP is announcing the launch of its new website, Yasmin Yaz Side Effects Lawyers. The site will serve as a news and information resource concerning the birth control pills Yaz, Yasmin and Ocella, which have been linked to an increased risk of blood clots, gallbladder disease and other side effects. More »
Hissey Kientz to Hold Testing Sessions for Victims of Asbestos Exposure
The law firm of Hissey Kientz, LLP is conducting two asbestos testing sessions in the El Paso, TX area for individuals who may have developed cancers such as mesothelioma or other asbestos-related diseases as a result of exposure to asbestos. Testing will be take place on Saturday, January 16 and Sunday, January 17, 2010. More »
Hissey Kientz, LLP Warns Birth Control Pill Users Of Increased Health Risks To Those Who Have Or Are Taking Yaz or Yasmin
The law firm of Hissey Kientz, LLP is warning all women using the birth control pills Yaz or Yasmin that they may face an increased risk of blood clots, heart attack, stroke, pulmonary embolism, deep vein thrombosis and other significant side effects as a result of the defective design of these products. Women taking Yaz and Yasmin are twice as likely to develop blood clots compared with other forms of birth control, according to two studies published in the British Medical Journal. More »
Hormone Therapy Victims Win Important Appeal
On November 2, 2009, the United States Court of Appeals for the Eighth Circuit issued its long-awaited decision in Scroggin v. Wyeth (Case No. 08-2555). The decision gives the green light for federal trials on Wyeth’s and Pfizer’s hormone therapy drugs. In affirming judgment on a jury verdict of compensatory damages, the federal appellate court rejected the defendants’ claims that plaintiffs like Donna Scroggin cannot prove that hormone therapy caused their breast cancer. It also found that the statute of limitations began to run from the announcement of the startling results of the Women’s Health Initiative study (“WHI”) in July, 2002. More »